IPSIndian Journal of Pharmacology
Home  IPS  Feedback Subscribe Top cited articles Login 
Users Online : 444 
Small font sizeDefault font sizeIncrease font size
Navigate Here
 »   Next article
 »   Previous article
 »   Table of Contents

Resource Links
 »   Similar in PUBMED
 »  Search Pubmed for
 »  Search in Google Scholar for
 »Related articles
 »   Citation Manager
 »   Access Statistics
 »   Reader Comments
 »   Email Alert *
 »   Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed1356    
    Printed72    
    Emailed0    
    PDF Downloaded177    
    Comments [Add]    

Recommend this journal

 

 RESEARCH PAPER
Year : 1993  |  Volume : 25  |  Issue : 3  |  Page : 154-157

Effect of amiodarone on the pharmacokinetics and hypoglycaemic activity of tolbutamide in rabbits



Correspondence Address:
YSR Krishnaiah


Login to access the Email id

Source of Support: None, Conflict of Interest: None


Rights and PermissionsRights and Permissions

Amiodarone was reported to elevate the serum levels of several drugs including digoxin, flecainide, quinidine, phenytoin and warfarin. The effect of amiodarone on the pharmacokinetics and hypoglycaemic activity of tolbutamide was studied initially in a rabbit model to find out the possible drug interaction such that the clinical relevance can be studied if necessary at a later stage. Amiodarone (100 mg/kg, oral once daily for one week) significantly increased the absorption rate constant, terminal half-life and AUC0-( of tolbutamide (40 mg/kg, oral) in normal rabbits. The hypoglycaemic activity of tolbutamide was also enhanced and prolonged sig-nificantly in amiodarone treated rabbits. It appears that amiodarone increased the absorption and decreased the hepatic metabolism of tolbutamide in rabbits. Further studies are needed to find out the clinical relevance of this tolbutamide-amiodarone interaction observed in rabbits.






[PDF]*


        
Print this article     Email this article

Site Map | Home | Contact Us | Feedback | Copyright and Disclaimer
Online since 20th July '04
Published by Wolters Kluwer - Medknow